RZLT
Rezolute, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Buy
+42/100
Last price
4.38
▲ 0.06 (1.39%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
4.39
Prev close
4.32
Day high
4.56
Day low
4.23
Volume
1.69M
Market cap
$423.64M
P/E (TTM)
—
52W range
1.07 – 11.46
Day trading desk
Gap from prior close
+1.62%
Prior close 4.32
VWAP
4.41
-0.71% from price
Relative volume
1.09×
Normal
Session range
7.80%
4.23 – 4.56
Position in range
45%
Mid range
ATR (14D)
0.31
7.08% of price
Prior day high
4.64
PDH
Prior day low
4.15
PDL
Bid / ask spread
—
Quote not published
Session volume
1.62M
Avg 1.48M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+5.80%
+3.9%
1M
-0.45%
-1.9%
3M
-14.62%
-18.0%
6M
+23.03%
+8.1%
YTD
+85.59%
+71.6%
1Y
-50.28%
-66.0%
3Y
+253.23%
+171.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RZLT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
9.42M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 30, 26 | EVANS DARON Chief Financial Officer |
BUY | 10.00K | $28.50K | Direct |
| Dec 16, 25 | HOGENHUIS WLADIMIR Director |
BUY | 5.65K | $9.55K | Direct |
| Dec 16, 25 | ROBERTS BRIAN KENNETH Officer |
BUY | 28.00K | $47.60K | Direct |
| Dec 15, 25 | ELAM NEVAN C Chief Executive Officer |
BUY | 32.00K | $50.88K | Direct |
| Dec 15, 25 | EVANS DARON Chief Financial Officer |
BUY | 45.00K | $79.58K | |
| Dec 15, 25 | KARNAWAT SUNIL RATILAL Officer |
BUY | 12.10K | $19.60K | Direct |
| Nov 19, 25 | ELAM NEVAN C Chief Executive Officer |
STOCK | 317.00K | $0 | Direct |
| Nov 19, 25 | LABRUCHERIE GILBERT M JR Director |
STOCK | 21.00K | $0 | Direct |
| Nov 19, 25 | EVANS DARON Chief Financial Officer |
STOCK | 107.00K | $0 | Direct |
| Nov 19, 25 | KREHER NERISSA C Director |
STOCK | 21.00K | $0 | Direct |
| Nov 19, 25 | HOGENHUIS WLADIMIR Director |
STOCK | 21.00K | $0 | Direct |
| Nov 19, 25 | KIM YOUNG-JIN Director |
STOCK | 21.00K | $0 | Direct |
| Nov 19, 25 | HARRIS ERIK Director |
STOCK | 21.00K | $0 | Direct |
| Nov 19, 25 | FAUCHET PHILIPPE Director |
STOCK | 21.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ELAM NEVAN C |
Chief Executive Officer | 641.12K | Purchase |
EVANS DARON |
Chief Financial Officer | 511.46K | Purchase |
FAUCHET PHILIPPE |
Director | 55.50K | Stock Award(Grant) |
HARRIS ERIK |
Director | 21.00K | Stock Award(Grant) |
HOGENHUIS WLADIMIR |
Director | 119.67K | Purchase |
KARNAWAT SUNIL RATILAL |
Officer | 81.44K | Purchase |
KIM YOUNG-JIN |
Director | 8.59M | Stock Award(Grant) |
KREHER NERISSA C |
Director | 58.58K | Stock Award(Grant) |
LABRUCHERIE GILBERT M JR |
Director | 109.07K | Stock Award(Grant) |
ROBERTS BRIAN KENNETH |
Officer | 323.85K | Purchase |
Fundamentals
Market cap$423.64M
Enterprise value$316.78M
Revenue (TTM)—
Gross profit—
EBITDA$-81.44M
Net income$-77.59M
EPS (TTM)$-0.75
Free cash flow$-36.37M
Total cash$107.80M
Total debt$934.00K
Book value / share$1.04
Shares outstanding96.72M
Float60.90M
Short % of float26.24%
Dividend yield0.00%
Beta (5Y)0.54
Valuation & profitability ratios
Trailing P/E—
Forward P/E-9.35
PEG ratio—
Price / sales—
Price / book4.20
EV / revenue—
EV / EBITDA-3.89
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-59.04%
Return on assets-35.32%
Debt / equity0.93
Current ratio9.68
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $61.53M | $55.74M | $43.81M | $32.49M | +10.4% |
| Selling, general & admin | $18.37M | $14.68M | $12.18M | $9.36M | +25.1% |
| Total operating expense | $79.89M | $70.42M | $55.99M | $41.61M | +13.4% |
| Operating income | -$79.89M | -$70.42M | -$55.99M | -$41.61M | -13.4% |
| Net interest income | $5.48M | $4.87M | $4.21M | -$1.73M | +12.6% |
| Pre-tax income | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -8.7% |
| Net income | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -8.7% |
| Net income to common | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -8.7% |
| Basic EPS | -0.98 | -1.33 | -1.01 | -2.26 | +26.3% |
| Diluted EPS | -0.98 | -1.33 | -1.01 | -2.32 | +26.3% |
| EBIT | -$79.89M | -$70.42M | -$55.99M | -$39.25M | -13.4% |
| EBITDA | -$79.86M | -$70.39M | -$55.96M | -$39.24M | -13.5% |
| Basic shares | 76.00M | 51.47M | 51.19M | 18.20M | +47.7% |
| Diluted shares | 76.00M | 51.47M | 51.19M | 19.49M | +47.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $94.11M | $70.40M | $16.04M | $150.41M | +33.7% |
| Cash & short-term investments | $167.86M | $126.87M | $101.90M | $150.41M | +32.3% |
| Total current assets | $171.15M | $128.65M | $104.91M | $152.10M | +33.0% |
| Property, plant & equipment | $1.42M | $1.98M | $2.19M | $168.00K | -28.4% |
| Total assets | $175.49M | $132.74M | $123.72M | $152.42M | +32.2% |
| Total current liabilities | $11.91M | $9.61M | $5.20M | $2.46M | +24.0% |
| Total debt | $1.61M | $2.23M | $2.48M | $188.00K | -27.5% |
| Total liabilities | $13.36M | $11.73M | $7.55M | $2.95M | +13.9% |
| Retained earnings | -$403.86M | -$329.44M | -$260.99M | -$209.20M | -22.6% |
| Shareholder equity | $162.13M | $121.00M | $116.17M | $149.47M | +34.0% |
| Working capital | $159.23M | $119.05M | $99.71M | $149.64M | +33.8% |
| Net tangible assets | $162.13M | $121.00M | $116.17M | $149.47M | +34.0% |
| Shares issued | 87.00M | 53.25M | 36.83M | 33.58M | +63.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$74.41M | -$68.46M | -$51.79M | -$41.06M | -8.7% |
| Depreciation & amortisation | $31.00K | $36.00K | $30.00K | $13.00K | -13.9% |
| Stock-based compensation | $7.12M | $7.36M | $7.27M | $3.69M | -3.2% |
| Change in working capital | $47.00K | $3.10M | $1.02M | -$642.00K | -98.5% |
| Operating cash flow | -$69.08M | -$57.37M | -$44.48M | -$39.62M | -20.4% |
| Capital expenditure | — | — | -$153.00K | — | — |
| Investing cash flow | -$14.54M | $48.70M | -$101.46M | $0 | -129.9% |
| Financing cash flow | $107.33M | $63.03M | $11.57M | $148.98M | +70.3% |
| Free cash flow | -$69.08M | -$57.37M | -$44.63M | -$39.62M | -20.4% |
| End cash position | $94.11M | $70.40M | $16.04M | $150.41M | +33.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $11.41M | $14.35M | $13.15M | $20.86M | $15.28M | -20.5% |
| Selling, general & admin | $5.95M | $9.87M | $6.67M | $4.99M | $4.74M | -39.7% |
| Total operating expense | $17.37M | $24.22M | $19.82M | $25.85M | $20.02M | -28.3% |
| Operating income | -$17.37M | -$24.22M | -$19.82M | -$25.85M | -$20.02M | +28.3% |
| Net interest income | $1.20M | $1.45M | $1.68M | $1.45M | $1.11M | -17.4% |
| Pre-tax income | -$16.17M | -$22.77M | -$18.15M | -$24.39M | -$18.91M | +29.0% |
| Net income | -$16.17M | -$22.77M | -$18.15M | -$24.39M | -$18.91M | +29.0% |
| Net income to common | -$16.17M | -$22.77M | -$18.15M | -$24.39M | -$18.91M | +29.0% |
| Basic EPS | -0.16 | -0.22 | -0.18 | -0.26 | -0.27 | +27.3% |
| Diluted EPS | -0.16 | -0.22 | -0.18 | -0.26 | -0.27 | +27.3% |
| EBIT | -$17.37M | -$24.22M | -$19.82M | -$25.85M | -$20.02M | +28.3% |
| EBITDA | -$17.36M | -$24.21M | -$19.81M | -$25.84M | -$20.02M | +28.3% |
| Basic shares | 104.04M | 103.69M | 103.42M | 94.34M | 70.03M | +0.3% |
| Diluted shares | 104.04M | 103.69M | 103.42M | 94.34M | 70.03M | +0.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.24M | $11.94M | $9.10M | $94.11M | $14.60M | -5.9% |
| Cash & short-term investments | $120.27M | $132.94M | $152.19M | $167.86M | $86.89M | -9.5% |
| Total current assets | $122.05M | $135.11M | $154.71M | $171.15M | $88.73M | -9.7% |
| Property, plant & equipment | $967.00K | $1.12M | $1.27M | $1.42M | $1.56M | -13.7% |
| Total assets | $125.46M | $138.63M | $158.66M | $175.49M | $94.74M | -9.5% |
| Total current liabilities | $7.70M | $9.53M | $10.21M | $11.91M | $10.53M | -19.2% |
| Total debt | $1.11M | $1.28M | $1.45M | $1.61M | $1.77M | -13.5% |
| Total liabilities | $8.63M | $10.63M | $11.50M | $13.36M | $12.17M | -18.9% |
| Retained earnings | -$460.95M | -$444.78M | -$422.01M | -$403.86M | -$379.47M | -3.6% |
| Shareholder equity | $116.83M | $128.00M | $147.17M | $162.13M | $82.57M | -8.7% |
| Working capital | $114.34M | $125.58M | $144.50M | $159.23M | $78.21M | -8.9% |
| Net tangible assets | $116.83M | $128.00M | $147.17M | $162.13M | $82.57M | -8.7% |
| Shares issued | 96.29M | 95.55M | 91.04M | 87.00M | 60.54M | +0.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$16.17M | -$22.77M | -$18.15M | -$24.39M | -$18.91M | +29.0% |
| Depreciation & amortisation | $8.00K | $7.00K | $8.00K | $8.00K | $7.00K | +14.3% |
| Stock-based compensation | $4.42M | $3.41M | $2.53M | $2.37M | $1.91M | +29.6% |
| Change in working capital | -$1.66M | -$398.00K | -$1.18M | $229.00K | -$36.00K | -316.3% |
| Operating cash flow | -$13.73M | -$20.32M | -$17.43M | -$22.00M | -$17.40M | +32.4% |
| Investing cash flow | $12.28M | $22.81M | -$68.49M | $346.00K | $23.05M | -46.2% |
| Financing cash flow | $747.00K | $356.00K | $911.00K | $101.16M | $10.00K | +109.8% |
| Free cash flow | -$13.73M | -$20.32M | -$17.43M | -$22.00M | -$17.40M | +32.4% |
| End cash position | $11.24M | $11.94M | $9.10M | $94.11M | $14.60M | -5.9% |
Options analytics
Put / call volume
2.12
Put-heavy session
Put / call open interest
0.04
Positioning, not flow
Max pain
2.50
-42.9% from spot
ATM implied vol
180.5%
Nearest strike to spot
Skew (10% OTM)
+113.3%
Puts bid over calls
Call volume
26
Contracts, this expiry
Put volume
55
Contracts, this expiry
Heaviest call OI
5.00
3.66K contracts
Heaviest put OI
2.50
165 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.14 | -0.20 | -40.4% |
| Mar 2026 | -0.17 | — | — |
| Dec 2025 | -0.18 | -0.22 | -22.2% |
| Sep 2025 | -0.26 | -0.18 | +31.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.19 | 8 | $0 | 0.0% |
| Next quarter | -0.17 | 8 | $0 | 0.0% |
| Current year | -0.70 | 9 | $2.09M | 0.0% |
| Next year | -0.47 | 7 | $54.09M | +2,482.3% |
Analyst targets & ownership
Mean target$9.80
High target$15.00
Low target$6.00
Implied upside123.74%
Analyst count10
ConsensusSTRONG BUY
Strong buy / Buy2 / 8
Hold0
Sell / Strong sell0 / 0
Held by insiders9.74%
Held by institutions98.37%
Institutions holding197
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
4.14
+5.90% from price
SMA 20
4.09
+7.00% from price
SMA 50
4.46
-1.85% from price
SMA 100
4.43
-1.16% from price
SMA 200
3.74
+17.17% from price
EMA 12
4.18
+4.75% from price
EMA 26
4.24
+3.38% from price
EMA 50
4.34
+0.99% from price
RSI (14)
55.0
Neutral
MACD (12,26,9)
-0.06
Hist 0.06
ATR (14)
0.31
7.08% of price
Realised vol 30D
53.0%
Annualised
Bollinger upper
4.40
20, 2σ
Bollinger lower
3.79
20, 2σ
50 / 200 cross
Golden
4.46 vs 3.74
Trend bias
Above 200
+17.17%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.96
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
53.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-87.2%
Peak to trough
Max drawdown 5Y
-90.3%
Peak to trough
ATR 14
0.31
7.08% of price
Beta (reported)
0.54
5Y monthly, from filing
Short interest
Shares short
16.81M
Prior 16.52M
Change vs prior
+1.8%
Shorts adding
% of float
26.24%
Heavily shorted
% of shares out
17.44%
Against total outstanding
Days to cover
12.3
Crowded exit
Float
60.90M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 26 | Lake Street | MAINTAINED | Buy | Buy |
| Oct 6, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Oct 6, 26 | Cantor Fitzgerald | UPGRADE | Neutral | Overweight |
| Sep 30, 26 | Lake Street | INITIATED | — | Buy |
| Sep 29, 26 | Craig-Hallum | UPGRADE | Hold | Buy |
| Sep 25, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 15, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jun 3, 26 | Maxim Group | MAINTAINED | Buy | Buy |
| Jun 3, 26 | Citizens | UPGRADE | Market Perform | Market Outperform |
| Jun 3, 26 | Wedbush | MAINTAINED | Outperform | Outperform |
| Jun 2, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 2, 26 | BTIG | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateOct 13, 2020
Last split1:50
Split dateOct 13, 2020
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-05
Periodic Financial Reports
10-K · 2026-09-24
Corporate Changes & Voting Matters
8-K · 2026-06-02
Corporate Changes & Voting Matters
8-K · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-04
Corporate Changes & Voting Matters
8-K · 2026-03-24
Periodic Financial Reports
10-Q · 2026-02-12
Corporate Changes & Voting Matters
8-K · 2026-01-07
Headlines
Cantor Fitzgerald Upgrades Rezolute to Overweight From Neutral
MT Newswires · 2d ago
Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’
Stocktwits · 3d ago
Rezolute Says FDA Recommends Pre-BLA Meeting for Congenital Hyperinsulinism Treatment
MT Newswires · 3d ago
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
GlobeNewswire · 3d ago
Craig-Hallum Upgrades Rezolute to Buy From Hold, Price Target is $7
MT Newswires · 9d ago
Rezolute Fiscal Q4 Loss Narrows
MT Newswires · 13d ago
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
GlobeNewswire · 13d ago
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · 28d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.